Jemperli (dostarlimab) receives US FDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer
,    -  GSK

Stephan: This is more technical than I usually run in SR but it is a special kind of good health news. If you or anyone you know has rectal cancer this may be important. If that is an issue giovve it to your physician or give it to them to give to their physician.

![](https://ww … ⌘ Read more